Valuation: AVRA Medical Robotics, Inc.

Market Cap 668M 586M 540M 506M 948M 63.06B 968M 6.49B 2.51B 31.16B 2.51B 2.46B 108B P/E 2026 *
-55.7x
P/E 2027 * -55.7x
Enterprise Value 668M 586M 540M 506M 948M 63.06B 968M 6.49B 2.51B 31.16B 2.51B 2.46B 108B EV / Sales 2026 *
11.3x
EV / Sales 2027 * 8.89x
Free-Float
-
Yield 2026 *
-
Yield 2027 * -
Change 5-day change 1-year change 3-year change Capi.($)
-3.50%-.--% - - 51.19M
-0.48%+7.20%-5.65%+3.69% 46.2B
+2.19%+11.71%+393.31%+609.31% 38.71B
+2.53%+13.93%+21.38%-10.96% 31.9B
+1.65%+3.61%+16.04%+55.24% 31.12B
-4.16%-2.58%+8.94%+26.14% 23.77B
-0.32%+12.96% - - 16.2B
+1.37%+14.53%+69.64%+136.34% 15.05B
+1.00%+10.30%+13.31%+23.36% 13.74B
+3.63%+9.53%+103.97%+106.25% 13.42B
Average +0.39%+9.14%+77.62%+118.67% 25.57B
Weighted average by Cap. +0.75%+8.71%+88.75%+138.12%

Financials

2026 *2027 *
Net sales 59.4M 52.08M 48.01M 44.95M 84.28M 5.6B 86.03M 577M 223M 2.77B 223M 218M 9.6B 75.2M 65.94M 60.78M 56.9M 107M 7.09B 109M 730M 283M 3.51B 282M 276M 12.16B
Net income -12M -10.52M -9.7M -9.08M -17.03M -1.13B -17.38M -117M -45.11M -559M -45.06M -44.08M -1.94B -14M -12.28M -11.31M -10.59M -19.86M -1.32B -20.28M -136M -52.62M -653M -52.57M -51.42M -2.26B
Net Debt - -
Logo AVRA Medical Robotics, Inc.
SS Innovations International, Inc., formerly AVRA Medical Robotics, Inc, is a medical robotics company. The Company is engaged in developing a fully autonomous medical robotic system using its software, which integrates artificial intelligence (AI) and deep learning, or machine learning (DL). By using an AI and DL-enhanced software program, it is creating an intelligent robotic system that robotizes a range of medical procedures. It is developing a treatment-independent autonomous robotics system utilizing its AI-driven precision guidance system, applicable to a variety of minimally and non-invasive procedures, with a focus on skin resurfacing aesthetic procedures. Its medical robotic system is being developed to deliver skin resurfacing treatments, such as micro-needling and laser therapies. Its autonomous medical robotics system is being developed to be compatible with available surgical tools and end-effectors, enabling it to enter the micro-needling and laser solutions market.
Employees
-